Get the Stockscreener App
22.42
0.95%
0.21
Overview
News
Price History
Option Chain
Financials
Why TEVA Down?
Discussions
Forecast
Stock Split
Dividend History
Teva Pharmaceutical Industries Ltd Adr stock is traded at $22.42, with a volume of 3.01M.
It is up +0.95% in the last 24 hours and up +30.96% over the past month.
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
See More
Previous Close:
$22.21
Open:
$22.27
24h Volume:
3.01M
Relative Volume:
0.40
Market Cap:
$25.41B
Revenue:
$16.77B
Net Income/Loss:
$-959.00M
P/E Ratio:
-11.21
EPS:
-2
Net Cash Flow:
$1.37B
1W Performance:
+7.38%
1M Performance:
+30.96%
6M Performance:
+35.96%
1Y Performance:
+113.93%
1-Day Range:
$22.19
$22.50
1-Week Range:
$20.40
$22.50
52-Week Range:
$10.34
$22.50
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
Name
Teva Pharmaceutical Industries Ltd Adr
Sector
Phone
972 (3) 914-8213
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Compare TEVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.25 | 25.41B | 16.77B | -959.00M | 1.37B | -0.85 |
|
ZTS
Zoetis Inc
|
164.70 | 74.13B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.745 | 43.93B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.16 | 41.58B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
VTRS
Viatris Inc
|
12.38 | 14.57B | 15.05B | -883.30M | 1.89B | -0.74 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-24 | Upgrade | Argus | Hold → Buy |
| Mar-08-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-12-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-23-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Upgrade | Piper Sandler | Underweight → Neutral |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Nov-27-23 | Upgrade | UBS | Neutral → Buy |
| Jul-06-23 | Upgrade | UBS | Sell → Neutral |
| May-25-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-14-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-04-22 | Downgrade | UBS | Neutral → Sell |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Aug-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-14-22 | Resumed | UBS | Neutral |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-04-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Apr-05-22 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-25-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-27-22 | Downgrade | Argus | Buy → Hold |
| Oct-28-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-04-21 | Downgrade | UBS | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-25-20 | Initiated | Oppenheimer | Perform |
| Aug-06-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-27-20 | Resumed | Goldman | Neutral |
| Jun-01-20 | Upgrade | SunTrust | Hold → Buy |
| Apr-24-20 | Resumed | Citigroup | Neutral |
| Apr-06-20 | Upgrade | UBS | Neutral → Buy |
| Feb-24-20 | Downgrade | Edward Jones | Hold → Sell |
| Nov-12-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Oct-17-19 | Upgrade | Gabelli & Co | Hold → Buy |
| Aug-07-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-19-19 | Initiated | Wolfe Research | Peer Perform |
| Jul-15-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-10-19 | Resumed | Credit Suisse | Neutral |
| Jul-05-19 | Upgrade | Argus | Hold → Buy |
| Jun-11-19 | Initiated | Barclays | Underweight |
| Jun-03-19 | Upgrade | Oppenheimer | Perform → Outperform |
| May-30-19 | Downgrade | BofA/Merrill | Buy → Underperform |
| May-28-19 | Downgrade | UBS | Buy → Neutral |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-07-19 | Resumed | UBS | Buy |
View All
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Latest News
Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Inkl
Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Is Kingsoft Cloud (KC) Outperforming Other Computer and Technology Stocks This Year? - Yahoo Finance
Opera Gains 27% in 3 Months: Should You Buy, Sell or Hold the Stock? - Yahoo Finance
Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - Yahoo Finance
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Hello Group Inc. Sponsored ADR (MOMO) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance
Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Investor's Business Daily
Saudi Arabia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Why Sony Group Corporation (SONY) Is One of the Best ADR Stocks to Invest in? - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
New Strong Buy Stocks for November 26th - Yahoo Finance
Why MINISO Group Holding Limited Unsponsored ADR (MNSO) Outpaced the Stock Market Today - Yahoo Finance
Petrobras to Distribute R$ 20 Billion in Dividends - Yahoo Finance
10 Stocks With the Largest Fair Value Estimate Increases After Q3 Earnings - Morningstar
Is Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
UK Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
XPeng Inc. Sponsored ADR (XPEV) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Sea Limited Q3 Earnings Miss Estimates, Shares Rise on Revenue Growth - Yahoo Finance
Such Is The Power Of CNH Industrial NV (NYSE: CNH) - Stocks Register
Hannover Rueck SE Reports Strong 2024 Earnings Growth - Yahoo Finance
11 New 4-Star Stocks - Morningstar
'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe. - Investor's Business Daily
XPeng Inc. Sponsored ADR (XPEV) Stock Moves -1.06%: What You Should Know - Yahoo Finance
Where Do Analysts See Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Heading? - Stocks Register
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.
Sea Limited Sponsored ADR (SE) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
South Africa Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Is Alstom (ALSMY) Outperforming Other Transportation Stocks This Year? - Yahoo Finance
Spain Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Italy Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Germany Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Is EXL Service (EXLS) Stock Outpacing Its Business Services Peers This Year? - Yahoo Finance
Is DMARKET Electronic Services & Trading (HEPS) Outperforming Other Retail-Wholesale Stocks This Year? - Yahoo Finance
Is AllianceBernstein (AB) Stock Outpacing Its Finance Peers This Year? - Yahoo Finance
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.28 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.
Is American Outdoor Brands (AOUT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
Weekly Upgrades and Downgrades - InvestorPlace
Monitoring Teva- Pharmaceutical Industries Ltd. ADR (TEVA) after recent insider movements - Knox Daily
Li Auto Inc. Sponsored ADR (LI) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Views of Wall Street’s Leading Experts on Teva- Pharmaceutical Industries Ltd. ADR - SETE News
Selling Buzz: Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Exec. VP, European Commercial Daniell Richard sells 98,943 shares of the company – Knox Daily - Knox Daily
Qifu Technology Inc. ADR (QFIN) gets rating Initiated from Nomura - Knox Daily
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 1.45 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):